Mustang Bio

Mustang Bio is a clinical-stage biopharmaceutical company focused on developing and commercializing gene therapies for patients suffering from rare genetic diseases. Their approach involves using lentiviral gene therapy to deliver functional genes to target cells, aiming to correct the underlying cause of diseases like X-linked severe combined immunodeficiency (X-SCID) and Fanconi anemia (FA).